70518 Federal Register / Vol. 71, No.

233 / Tuesday, December 5, 2006 / Notices

other than their time. The total Estimated Annualized Burden Hours
estimated annual burden hours are 300.

Average
Number of
Number of burden per
Respondents responses per
respondents response
respondent (in hours)

Participant Solicitation Telephone Screening Questionnaire ...................................................... 1200 1 5/60

Household Survey Questionnaire ................................................................................................ 600 1 20/60

Dated: November 28, 2006. FDA announced that a joint meeting of Proposed Project: Advanced Education
Joan F. Karr, Anti-Infective Drugs Advisory Nursing Traineeship (AENT) and Nurse
Acting Reports Clearance Officer, Centers for Committee and the Drug Safety and Risk Anesthetist Traineeship (NAT): In Use
Disease Control and Prevention. Management Advisory Committee Without Approval
[FR Doc. E6–20539 Filed 12–4–06; 8:45 am] would be held on December 14 and 15, The Health Resources and Services
BILLING CODE 4163–18–P 2006. On page 66545, in the first and Administration (HRSA) provides
column, the Location portion of training grants to educational
document is amended to read as institutions to increase the numbers of
DEPARTMENT OF HEALTH AND follows: advanced education nurses through the
HUMAN SERVICES Location: Hilton, Maryland Advanced Education Nursing
Ballrooms, 8727 Colesville Road, Silver Traineeship (AENT) program and the
Food and Drug Administration
Spring, MD. The hotel phone number is Nurse Anesthetist Traineeship (NAT)
Joint Meeting of the Anti-Infective 301–589–5200. program.
Drugs Advisory Committee and the This notice is issued under the HRSA developed the AENT and NAT
Drug Safety and Risk Management Federal Advisory Committee Act (5 tables for the guidance applications for
Advisory Committee; Amendment of U.S.C. app. 2) and 21 CFR part 14, the two nursing traineeship programs.
Notice relating to the advisory committees. The AENT and NAT tables are used
annually by grant applicants that are
AGENCY: Food and Drug Administration, Dated: November 29, 2006. applying for AENT and NAT funding.
HHS. Randall W. Lutter, The funds appropriated for the AENT
ACTION: Notice. Associate Commissioner for Policy and and NAT programs are distributed
Planning. among eligible institutions based on a
The Food and Drug Administration [FR Doc. E6–20538 Filed 12–5–06; 8:45 am] formula. Award amounts are based on
(FDA) is announcing an amendment to enrollment and graduate data reported
BILLING CODE 4160–01–S
the notice of joint meeting of the Anti- on the tables and two funding factors
Infective Drugs Advisory Committee (Statutory Funding Preference and
and the Drug Safety and Risk DEPARTMENT OF HEALTH AND Statutory Special Consideration) to
Management Advisory Committee. This HUMAN SERVICES those institutions which the criteria for
meeting was announced in the Federal one or both of the funding factors.
Register of November 15, 2006 (71 FR Health Resources and Services The AENT/NAT tables include
66545). The amendment is being made Administration information on program participants
to reflect a change in the Location such as the number of enrollees, number
portion of the document. There are no Agency Information Collection of graduates and the types of programs
other changes. Activities: Submission for OMB they are enrolling into and/or from
FOR FURTHER INFORMATION CONTACT: Review; Comment Request which they are graduating. These tables
Sohail Mosaddegh, Center for Drug will be available electronically through
Evaluation and Research (HFD–21), Periodically, the Health Resources Grants.gov. AENT and NAT applicants
Food and Drug Administration, 5600 and Services Administration (HRSA) will have a single access point to submit
Fishers Lane (for express delivery, 5630 publishes abstracts of information their grant applications and AENT/NAT
Fishers Lane, rm. 1093) Rockville, MD collection requests under review by the Traineeship tables.
20857, 301–827–7001, fax: 301–827– Office of Management and Budget Data from the tables will be used in
6776, e-mail: (OMB), in compliance with the the award determination and validation
sohail.mosaddegh@fda.hhs.gov, or FDA Paperwork Reduction Act of 1995 (44 process. Additionally, the data will be
Advisory Committee Information Line, U.S.C. Chapter 35). To request a copy of used to ensure programmatic
1–800–741–8138 (301–443–0572 in the the clearance requests submitted to compliance, report to Congress and
Washington DC area), codes 301–451– OMB for review, call the HRSA Reports policymakers on the program
2530 or 301–451–2535. Please call the Clearance Office on (301) 443–1129. accomplishments, and formulate and
Information Line for up-to-date The following request has been justify future budgets for these activities
information on this meeting. submitted to the Office of Management submitted to OMB and Congress.
SUPPLEMENTARY INFORMATION: In the and Budget for review under the The burden estimate for this project is
Federal Register of November 15, 2006, Paperwork Reduction Act of 1995: as follows:
ycherry on PROD1PC64 with NOTICES

Responses
Number of Total Hours per Total burden
Form per
respondents responses response hours
respondent

AENT .................................................................................... 500 1 500 1 500

VerDate Aug<31>2005 15:14 Dec 04, 2006 Jkt 211001 PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 E:\FR\FM\05DEN1.SGM 05DEN1